Giuseppa Pistritto

Rome, 00187, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

The Sweet Side of HIPK2.

The Sweet Side of HIPK2.

Journal: Cancers
Published: March 27, 2023

HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases.

HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases.

Journal: Cancers
Published: January 11, 2023

HIPK2 as a Novel Regulator of Fibrosis.

HIPK2 as a Novel Regulator of Fibrosis.

Journal: Cancers
Published: December 23, 2022

The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study.

The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study.

Journal: Biomolecules
Published: February 17, 2022

P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex.

P62/SQSTM1/Keap1/NRF2 Axis Reduces Cancer Cells Death-Sensitivity in Response to Zn(II)-Curcumin Complex.

Journal: Biomolecules
Published: February 09, 2021

A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.

A ruthenium(II)-curcumin compound modulates NRF2 expression balancing the cancer cell death/survival outcome according to p53 status.

Journal: Journal of experimental & clinical cancer research : CR
Published: June 04, 2020

Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response.

Reduced chemotherapeutic sensitivity in high glucose condition: implication of antioxidant response.

Journal: Oncotarget
Published: April 23, 2019

The Horizon Scanning System at The Italian Medicines Agency.

The Horizon Scanning System at The Italian Medicines Agency.

Journal: Drug discovery today
Published: December 21, 2018

Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique.

Innovative Therapeutic Strategies for Cystic Fibrosis: Moving Forward to CRISPR Technique.

Journal: Frontiers in pharmacology
Published: February 02, 2018

p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions.

p53-Dependent PUMA to DRAM antagonistic interplay as a key molecular switch in cell-fate decision in normal/high glucose conditions.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 26, 2017

Neuro-differentiated Ntera2 cancer stem cells encapsulated in alginate beads: First evidence of biological functionality.

Neuro-differentiated Ntera2 cancer stem cells encapsulated in alginate beads: First evidence of biological functionality.

Journal: Materials science & engineering. C, Materials for biological applications
Published: January 23, 2017

Hyperglycemia triggers HIPK2 protein degradation.

Hyperglycemia triggers HIPK2 protein degradation.

Journal: Oncotarget
Published: August 04, 2016
Showing 1-12 of 18

Last Updated: 09/26/2026